EMIT: Targeted Radio Therapy Overcoming the technical, regulatory and clinical challenges in targeted radio therapy 30 – 31 January 2013
Washington, D.C.

Past Media Partners


  • IOS Press www.iospress.nl

  • Journal of Labelled Compounds & Radiopharmaceuticals The Journal of Labelled Compounds and Radiopharmaceuticals publishes original scientific manuscripts dealing with all aspects of research in labelled compound preparation and application. wileyonlinelibrary.com/journal/jlcr Read more...

  • Wiley wileyonlinelibrary.com

  • Cancer Biology and Therapy www.cbt.msubmit.net

  • Bentham Science Publishers Ltd www.benthamscience.com

  • Cancer Biotherapy and Radiopharmaceuticals Cancer Biotherapy and Radiopharmaceuticals is the authoritative peer-reviewed journal covering cutting-edge biotherapy and innovative investigations of methods to improve cancer therapy. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokines, gene therapy, cell-based therapies and other forms of immunotherapies. http://ow.ly/6NaJN

  • PharmaVOICE PharmaVOICE magazine, reaching more than 25,000 BPA-qualified life-sciences executives, is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. www.pharmavoice.com Read more...

  • mAbs www.landesbioscience.com

  • Pharmaphorum www.pharmaphorum.com

  • Drug Discovery World (DDW) For over a decade now, DDW has established itself as a highly respected and the ‘must read’ journal within the DD&D Arena. DDW is recognised for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised platform for Industry Gurus to debate some of the more challenging technological and business issues facing the the life science industry. www.ddw-online.com Read more...